COVID-19 Vaccine Tracker: India To Begin Vaccination For 18-45 From May 1

Covaxin To Be Rolled Out In Seven More States

Bharat Biotech's Covaxin is currently only available in 12 states. Chhattisgarh, Gujarat, Jharkhand, Kerala, Madhya Pradesh, Punjab, and West Bengal are expected to begin the roll out of Covaxin in the upcoming week

India Trains Immunisation Managers Of 13 Countries To Administer Covaxin

The Ministry of Health and Family Welfare trained Immunisation managers of thirteen countries- Bahrain, Bangladesh, Bhutan, Brazil, Maldives, Mauritius, Mongolia, Morocco, Myanmar, Nepal, Oman, Seychelles, and Sri Lanka for rolling out the Indian vaccine in their respective countries. This training was conducted over a period of two days. 

Vaccinations Cross 13 Lakhs

India has vaccinated over 13,90,592 health workers in six days of vaccination. Over 3,47,058 people were vaccinated on January 22. 

Five deaths have been reported across the country but the government believes that none of these are linked to vaccination.

1 Hospitalisation, Over 9 lakh Vaccinated

On the sixth day of COVID-19 vaccination, India vaccinated over 2,12,223 beneficiaries till 6 pm taking the total number of health workers who received vaccination to 9,99,065. 

There were no adverse events following immunization reported in the country, today. One person was hospitalised after receiving their first shot which the Health Ministry stated is not related to vaccination and no deaths were reported today. 

COWIN app updated

For further smoothening the COVID-19 vaccination process, the Ministry of Health and Family Welfare has brought about some enhancements to the COWIN application. 

Along with providing a pre-registered list of beneficiaries for specific sessions, the app now allows a new allotment wherein new beneficiaries can be selected to receive the vaccine in an ongoing session if they are not previously listed for the session. 

Beneficiaries will receive a provisional certificate after receiving the first dose and a final certificate after the second dose. 

10 hospitalisations, over 7 lakh vaccinated

On the fifth day of COVID-19 vaccination, India vaccinated over 1,12,007 beneficiaries till 6 pm taking the total number of health workers who received vaccination to 7,86, 842. 

Close to 10 people have been hospitalised following vaccination. While one person each in Uttarakhand, Chhattisgarh, Rajasthan, and three in Delhi have been discharged, one person in Delhi, two in Karnataka, and one in West Bengal are still under observation

Four deaths after COVID-19 vaccination

Four health workers have died post receiving COVID-19 vaccination across the country. The government, however, believes that none of the deaths were due to vaccination. 

One person died each in Telangana and Uttar Pradesh, while two deaths occurred in Karnataka. 

Over 6 lakh health workers vaccinated

Around 6,31,417 health workers have received either of the COVID- 19 vaccines in the country. On January 19, a total of 1.7 lakh health workers received vaccination. 

There were no adverse events following immunization reported in the country, today. Around nine people had to be hospitalised after receiving their first shot. 

India To Export COVID- 19 Vaccine To Neighbouring Countries

India is set to export doses of the COVID-19 vaccine to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles will begin from 20 January 2021.

In respect of Sri Lanka, Afghanistan and Mauritius, we are awaiting their confirmation of necessary regulatory clearances. 

This aligns with India's goals to fight this pandemic, the Ministry of External Affairs stated in a press release. 

The government will ensure that the domestic manufacturers will have adequate stocks to meet domestic requirements while supplying abroad.

India Considering A Nasal COVID-19 Vaccine

A nasal COVID-19 vaccine produced by Bharat Biotech has been identified by the Indian Council of Medical Research, NITI Aayog, and the Ministry of Health and Family Welfare as a potential vaccine candidate for India, announced Dr. V.K.Paul, member NITI Aayog. The vaccine manufacturer has approached the Central Drugs Standard Control Organisation for approval to begin Phase I/II trials in the country. 

Nasal vaccines have been used to tackle rotavirus before.